Cargando…

Development and validation of prognostic nomograms in patients with gallbladder mucinous adenocarcinoma: A population-based study

BACKGROUND: Gallbladder mucinous adenocarcinoma (GBMAC) is an uncommon malignant gallbladder tumor. There are few studies on its prognosis, with the majority consisting of small series or individual cases. We sought to develop and validate nomograms for predicting overall survival (OS) and cancer-sp...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Xiaoming, Wang, Jingzhi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9795173/
https://www.ncbi.nlm.nih.gov/pubmed/36591489
http://dx.doi.org/10.3389/fonc.2022.1084445
_version_ 1784860198985269248
author Xu, Xiaoming
Wang, Jingzhi
author_facet Xu, Xiaoming
Wang, Jingzhi
author_sort Xu, Xiaoming
collection PubMed
description BACKGROUND: Gallbladder mucinous adenocarcinoma (GBMAC) is an uncommon malignant gallbladder tumor. There are few studies on its prognosis, with the majority consisting of small series or individual cases. We sought to develop and validate nomograms for predicting overall survival (OS) and cancer-specific survival (CSS) in GBMAC patients. METHODS: The clinicopathological data of GBMAC patients from 1975 to 2019 was extracted from the Surveillance, Epidemiology, and End Results (SEER) database, and all patients were randomly divided into a training cohort (70%) and a validation cohort (30%). Using multivariate Cox regression analyses based on Akaike information criterion (AIC), prognostic and important variables for GBMAC were determined. On the basis of these factors, nomograms were developed to predict the 1-, 3-, and 5-year OS and CSS rates of patients with GBMAC. Multiple parameters, including the area under the subject operating characteristic curve (AUC), the calibration plots, and the decision curve analysis (DCA), were then used to evaluate the accuracy of nomograms. RESULTS: Following exclusion, a total of 707 GBMAC patients were enrolled, and the training cohort (490, 70%) and validation cohort (217, 30%) were randomly assigned. Grade, surgery, radiation, and SEER stage were predictive factors for patients with GBMAC, as indicated by univariate and multivariate Cox regression analyses based on AIC. We created nomograms for predicting OS and CSS in GBMAC using the four factors. The calibration curves and area under the curves (AUCs) indicated that our nomograms have a moderate degree of predictive accuracy and capability. The results of the DCA revealed that the nomogram has a high predictive value. CONCLUSION: We established the first nomograms for predicting 1-, 3-, and 5-year OS and CSS in GBMAC patients, thereby contributing to the prognostication of patients and clinical management.
format Online
Article
Text
id pubmed-9795173
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-97951732022-12-29 Development and validation of prognostic nomograms in patients with gallbladder mucinous adenocarcinoma: A population-based study Xu, Xiaoming Wang, Jingzhi Front Oncol Oncology BACKGROUND: Gallbladder mucinous adenocarcinoma (GBMAC) is an uncommon malignant gallbladder tumor. There are few studies on its prognosis, with the majority consisting of small series or individual cases. We sought to develop and validate nomograms for predicting overall survival (OS) and cancer-specific survival (CSS) in GBMAC patients. METHODS: The clinicopathological data of GBMAC patients from 1975 to 2019 was extracted from the Surveillance, Epidemiology, and End Results (SEER) database, and all patients were randomly divided into a training cohort (70%) and a validation cohort (30%). Using multivariate Cox regression analyses based on Akaike information criterion (AIC), prognostic and important variables for GBMAC were determined. On the basis of these factors, nomograms were developed to predict the 1-, 3-, and 5-year OS and CSS rates of patients with GBMAC. Multiple parameters, including the area under the subject operating characteristic curve (AUC), the calibration plots, and the decision curve analysis (DCA), were then used to evaluate the accuracy of nomograms. RESULTS: Following exclusion, a total of 707 GBMAC patients were enrolled, and the training cohort (490, 70%) and validation cohort (217, 30%) were randomly assigned. Grade, surgery, radiation, and SEER stage were predictive factors for patients with GBMAC, as indicated by univariate and multivariate Cox regression analyses based on AIC. We created nomograms for predicting OS and CSS in GBMAC using the four factors. The calibration curves and area under the curves (AUCs) indicated that our nomograms have a moderate degree of predictive accuracy and capability. The results of the DCA revealed that the nomogram has a high predictive value. CONCLUSION: We established the first nomograms for predicting 1-, 3-, and 5-year OS and CSS in GBMAC patients, thereby contributing to the prognostication of patients and clinical management. Frontiers Media S.A. 2022-12-14 /pmc/articles/PMC9795173/ /pubmed/36591489 http://dx.doi.org/10.3389/fonc.2022.1084445 Text en Copyright © 2022 Xu and Wang https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Xu, Xiaoming
Wang, Jingzhi
Development and validation of prognostic nomograms in patients with gallbladder mucinous adenocarcinoma: A population-based study
title Development and validation of prognostic nomograms in patients with gallbladder mucinous adenocarcinoma: A population-based study
title_full Development and validation of prognostic nomograms in patients with gallbladder mucinous adenocarcinoma: A population-based study
title_fullStr Development and validation of prognostic nomograms in patients with gallbladder mucinous adenocarcinoma: A population-based study
title_full_unstemmed Development and validation of prognostic nomograms in patients with gallbladder mucinous adenocarcinoma: A population-based study
title_short Development and validation of prognostic nomograms in patients with gallbladder mucinous adenocarcinoma: A population-based study
title_sort development and validation of prognostic nomograms in patients with gallbladder mucinous adenocarcinoma: a population-based study
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9795173/
https://www.ncbi.nlm.nih.gov/pubmed/36591489
http://dx.doi.org/10.3389/fonc.2022.1084445
work_keys_str_mv AT xuxiaoming developmentandvalidationofprognosticnomogramsinpatientswithgallbladdermucinousadenocarcinomaapopulationbasedstudy
AT wangjingzhi developmentandvalidationofprognosticnomogramsinpatientswithgallbladdermucinousadenocarcinomaapopulationbasedstudy